(Q46903259)

26 December 2017

title

Utilisation of non-steroidal anti-inflammatory drugs (NSAIDs) through community pharmacies in Malaysia (English)

1 reference

26 December 2017

0 references

S S Chua

1

1 reference

26 December 2017

T Paraidathathu

series ordinal

2

1 reference

26 December 2017

publication date

1 January 2005

1 reference

26 December 2017

Asia-Pacific Journal of Public Health

published in

1 reference

26 December 2017

volume

17

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

117-123

1 reference

26 December 2017

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury

cites work

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Use and benefits of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Nonsteroidal antiinflammatory drugs--differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Coxibs and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Cox-2 inhibitors: today and tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Gastrointestinal bleeds associated with rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Arthritis treatment in Hong Kong--cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

Vioxx: an unequal partnership between safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F101053950501700210

10.1177/101053950501700210

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017